WebLe Headache Impact Test (HIT) est un outil utilisé pour mesurer l’impact des maux de tête sur votre capacité à fonctionner au travail, à l’école, à la maison et dans des situations sociales. Votre pointage vous montre l’effet que les maux de tête ont sur la vie quotidienne normale et votre capacité à fonctionner. HIT a été ... Headaches that stop you from enjoying the important things in life, like family, work, school or social activities could be migraine. SCORE . Higher scores indicate a greater impact on your life . Score range 36-78 . Reference: Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6. TM)
Reliability and Validity of Turkish Version of Headache Impact Test ...
WebApr 4, 2008 · Background and purpose: Complete information on migraine-related disabilities facilitate the making of appropriate treatment decisions. Although the … WebIt is a clinically validated tool used to determine how severe your headaches are and assess the impact they’re having on your life. After you complete the test, you’re assigned a score that falls into one of the following categories: Little or no impact (46 or less) Some impact (50 -55) Substantial impact (56-59) scout climbing risk assessment
HIT-6™ HEADACHE IMPACT TEST - Treating TMJ
WebApr 11, 2024 · Background and Objectives Idiopathic intracranial hypertension (IIH) most typically occurs in women of childbearing age with increased weight as a key risk factor for development or exacerbation of the disease. Pregnancy is common in this group of patients. The longer-term effect of pregnancy on IIH has not been established and was the aim of … WebDec 6, 2024 · The short-form Headache Impact Test (HIT-6; Fig. 1) is a widely used PROM that assesses the negative impact of headaches on normal daily activity. 19 It was … WebFeb 21, 2024 · Background and Objectives The oral calcitonin gene–related peptide receptor antagonist atogepant is indicated for the preventive treatment of episodic migraine. We evaluated changes in patient-reported outcomes with atogepant in adults with migraine. Methods In this phase 3, 12-week, multicenter, randomized, double-blind, placebo … scout climbing holds